Lyrica CR 82.5 mg/1

Lyrica CR 82.5 mg is an extended-release formulation of pregabalin, used for managing certain types of nerve pain. This medication is designed to provide long-lasting relief and is commonly prescribed for neuropathic pain conditions.

Lyrica CR 82.5 mg is primarily used for the management of neuropathic pain, which is often described as sharp, burning, or electric shock-like pain. This medication is designed to provide extended relief, making it suitable for conditions that require consistent pain management. Pregabalin, the active ingredient, is often used for what is pregabalin used for, including diabetic nerve pain and postherpetic neuralgia.

Common effects of Lyrica CR 82.5 mg may include dizziness, drowsiness, and peripheral edema. Some users might experience weight gain or blurred vision. These effects can vary from person to person and may subside as the body adjusts to the medication.

Lyrica CR 82.5 mg should be handled with care, especially for individuals with a history of heart or kidney issues. It is important to follow the prescribed dosage and avoid abrupt discontinuation. Always consult a healthcare provider before starting or stopping any medication.

Lyrica CR 82.5 mg may interact with alcohol, leading to increased drowsiness. It can also interact with certain medications that affect the central nervous system, such as opioids or benzodiazepines. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.